XCNQPMED
Market cap1mUSD
Dec 24, Last price
0.01CAD
1D
0.00%
1Q
-50.00%
IPO
-83.33%
Name
Predictmedix Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
20.03%
Rev. gr., 5y
%
Revenues
0k
-100.00%
Net income
-2m
L-3.59%
CFO
-2m
L+207.58%
Earnings
Dec 26, 2024
Profile
Predictmedix Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. The company operates in two segments, Workplace Health and Safety, and Healthcare. It offers disease symptom screening solutions to identify persons who are more likely to test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. The company also develops impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | |
| Income | ||||||
Revenues | 35 -74.02% | 135 | ||||
Cost of revenue | 1,645 | 1,940 | 1,938 | |||
Unusual Expense (Income) | ||||||
NOPBT | (1,645) | (1,905) | (1,803) | |||
NOPBT Margin | ||||||
Operating Taxes | (118) | (151) | ||||
Tax Rate | ||||||
NOPAT | (1,645) | (1,788) | (1,652) | |||
Net income | (1,993) -3.59% | (2,068) 9.86% | (1,882) -2.66% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 1,638 | 495 | 1,090 | |||
BB yield | -17.64% | -6.19% | -8.42% | |||
| Debt | ||||||
Debt current | 38 | (15) | ||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | (37) | (41) | (227) | |||
| Cash flow | ||||||
Cash from operating activities | (1,643) | (534) | (1,532) | |||
CAPEX | (2) | (145) | (418) | |||
Cash from investing activities | (145) | (418) | ||||
Cash from financing activities | 1,601 | 547 | 1,682 | |||
FCF | (1,744) | (874) | (1,853) | |||
| Balance | ||||||
Cash | 37 | 79 | 211 | |||
Long term investments | ||||||
Excess cash | 37 | 77 | 205 | |||
Stockholders' equity | (144) | (153) | 887 | |||
Invested Capital | 1 | 38 | 667 | |||
ROIC | ||||||
ROCE | 1,144.02% | 1,649.45% | ||||
| EV | ||||||
Common stock shares outstanding | 142,926 | 114,168 | 107,925 | |||
Price | 0.07 -7.14% | 0.07 -41.67% | 0.12 -54.72% | |||
Market cap | 9,290 16.25% | 7,992 -38.29% | 12,951 -51.71% | |||
EV | 9,253 | 7,950 | 12,724 | |||
EBITDA | (1,605) | (1,746) | (1,724) | |||
EV/EBITDA | ||||||
Interest | 9 | 3 | ||||
Interest/NOPBT | ||||||